Kevin Lee Bicycle Therapeutics PLC (BCYC) insider trading activity

Kevin Lee is CHIEF EXECUTIVE OFFICER of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 475,310 shares of BCYC, which is worth approximately $3.06 Million. The most recent transaction as insider was on May 04, 2021, when has been sold 897 shares (Ordinary Shares) at a price of $14.0 per share, resulting in proceeds of $12,558. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 475K

1.14% 3M change

24.8% 12M change

Total Value Held $3.06 Million

Kevin Lee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 04 2021	BUY Exercise of conversion of derivative security	$12,558 $14.0 p/Share	897 Added 0.35%	255,631 Ordinary Shares
May 03 2021	SELL Open market or private sale	$109,055 $32.16 p/Share	3,391 Reduced 1.31%	254,734 Ordinary Shares
May 03 2021	BUY Exercise of conversion of derivative security	$47,474 $14.0 p/Share	3,391 Added 1.3%	258,125 Ordinary Shares
Apr 30 2021	SELL Open market or private sale	$923,734 $30.38 p/Share	30,406 Reduced 10.66%	254,734 Ordinary Shares
Apr 30 2021	BUY Exercise of conversion of derivative security	$425,684 $14.0 p/Share	30,406 Added 9.64%	285,140 Ordinary Shares
Apr 29 2021	SELL Open market or private sale	$184,452 $30.65 p/Share	6,018 Reduced 2.31%	254,734 Ordinary Shares
Apr 29 2021	BUY Exercise of conversion of derivative security	$84,252 $14.0 p/Share	6,018 Added 2.26%	260,752 Ordinary Shares
Apr 28 2021	SELL Open market or private sale	$715,791 $31.82 p/Share	22,495 Reduced 8.11%	254,734 Ordinary Shares
Apr 28 2021	BUY Exercise of conversion of derivative security	$314,930 $14.0 p/Share	22,495 Added 7.51%	277,229 Ordinary Shares
Apr 27 2021	SELL Open market or private sale	$205,981 $31.04 p/Share	6,636 Reduced 2.54%	254,734 Ordinary Shares
Apr 27 2021	BUY Exercise of conversion of derivative security	$92,904 $14.0 p/Share	6,636 Added 2.48%	261,370 Ordinary Shares
Apr 26 2021	SELL Open market or private sale	$578,244 $31.07 p/Share	18,611 Reduced 6.81%	254,734 Ordinary Shares
Apr 26 2021	BUY Exercise of conversion of derivative security	$203,630 $14.0 p/Share	14,545 Added 5.05%	273,345 Ordinary Shares
Feb 05 2021	SELL Open market or private sale	$3,100 $31.0 p/Share	100 Reduced 0.04%	258,800 Ordinary Shares
Jan 20 2021	SELL Open market or private sale	$38,062 $32.12 p/Share	1,185 Reduced 0.46%	258,900 Ordinary Shares
Jan 19 2021	SELL Open market or private sale	$150,750 $30.15 p/Share	5,000 Reduced 1.89%	260,085 Ordinary Shares
Jan 15 2021	SELL Open market or private sale	$135,050 $27.01 p/Share	5,000 Reduced 1.85%	265,085 Ordinary Shares
Jan 14 2021	SELL Open market or private sale	$125,000 $25.0 p/Share	5,000 Reduced 1.82%	270,085 Ordinary Shares

Kevin Lee

CHIEF EXECUTIVE OFFICER

Cambridge, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Value

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

Operation

Value

Type

News

Receive news related to BICYCLE THERAPEUTICS plc

Track Activities on BCYC

Account